Log in to save to my catalogue

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_516d057fd503452483e4b0dac563dcdb

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

ObjectivesIn this large multicentre study, we compared the effectiveness and safety of tocilizumab intravenous versus subcutaneous (SC) in 109 Takayasu arteritis (TAK) patients.MethodsWe conducted a retrospective multicentre study in referral centres from France, Italy, Spain, Armenia, Israel, Japan, Tunisia and Russia regarding biological-targeted...

Alternative Titles

Full title

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_516d057fd503452483e4b0dac563dcdb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_516d057fd503452483e4b0dac563dcdb

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2022-002830

How to access this item